Corneal Implants Market to grow with a CAGR of 6.36% through 2030
Increasing healthcare infrastructure and a supportive regulatory environment are expected to drive the Global Corneal Implants Market growth in the forecast period, 2026-2030.
According
to TechSci Research report, “Corneal Implants Market - Global Industry Size,
Share, Trends, Competition, Opportunity and Forecast, 2030”, Global Corneal Implants Market
has valued at USD 512.68 million in 2024 and is anticipated to witness an
impressive growth in the forecast period with a CAGR of 6.36% in the forecast period, 2026-2030. This
can be due to collaborations and partnerships among leading companies with a
diverse approach to merge the expertise of individual companies and to
strengthen their position in the market. Medical tourism can drive the demand
for the global corneal implants market, particularly in regions where
healthcare facilities are advanced, and costs are competitive. Medical tourism
refers to the practice of individuals traveling to other countries for medical
treatment, often to access high-quality healthcare services at a lower cost or
with shorter wait times. One of the primary reasons individuals engage in
medical tourism is the potential for cost savings. In some countries, the cost
of corneal implant procedures, including corneal transplantation, can be
significantly lower than in their home countries. This cost advantage can
attract patients seeking affordable yet high-quality healthcare. Medical
tourism allows patients to access specialized medical expertise and advanced
technologies that may not be readily available in their home countries. Some
medical facilities in popular medical tourism destinations are equipped with
state-of-the-art equipment and highly skilled healthcare professionals. Medical
tourists can combine their medical treatments with leisure travel. They can
explore new destinations, experience different cultures, and enjoy
post-operative recovery in pleasant surroundings, which can contribute to an
overall positive experience.
Additionally, approximately 200,000 corneal implant procedures are conducted each year. Additionally, there is a backlog of 12.7 million patients in need of corneal implants, indicating that only one out of every 70 individuals in need receives the treatment they require. Consequently, this substantial disparity between demand and supply is anticipated to be a driving force for the industry's expansion in the foreseeable future. Notably, corneal disease ranks as the fifth most prevalent cause of blindness on a global scale. In August 2022, in a pioneering achievement for India, a collaborative effort by researchers from L V Prasad Eye Institute (LVPEI), Hyderabad, the Indian Institute of Technology Hyderabad (IITH), and the centre for Cellular and Molecular Biology (CCMB), Hyderabad, has resulted in the successful 3D printing of an artificial cornea, followed by its transplantation into a rabbit's eye. This groundbreaking innovation was made possible by using human donor corneal tissue to create the 3D-printed cornea, which contains no synthetic components, is entirely natural, and is devoid of animal residues, ensuring its safety for use in patients. Through a combination of regenerative medicine and tissue engineering advancements, the researchers harnessed decellularized corneal tissue matrix and human eye-derived stem cells to develop a novel biomimetic hydrogel (currently pending a patent) as the base material for the 3D-printed cornea. Notably, this biocompatible and natural 3D-printed cornea is entirely sourced from human corneal tissue and does not contain any animal residues.
Browse
over XX market data Figures and spread through XX
Pages and an in-depth TOC on " Global Corneal Implants Market.”
Global Corneal Implants Market is segmented based on Type, Application, Surgery, and by region.
Based on type, human cornea category shows the fastest growth and is predicted to continue expanding over the coming years. Human donor corneal tissue, also known as allografts, is inherently biocompatible with the recipient's body. This reduces the risk of immune rejection and complications compared to synthetic or artificial materials. Human donor corneal tissue has a long history of successful use in corneal transplantation procedures. Surgeons are well-trained in performing surgeries using human tissue, which has contributed to its continued popularity. Many countries and regions have established eye banks and organ donation systems that provide a steady supply of human corneal tissue for transplantation. This availability makes it a convenient choice for many patients. Human tissue transplantation is well-regulated in most countries, ensuring that donor corneas are carefully screened, processed, and stored to meet stringent safety standards. This regulatory oversight adds to the trust and confidence in using human tissue. Human donor tissue can be used for a variety of corneal conditions, including full-thickness and partial-thickness transplants, making it versatile in addressing different patient needs. Many cultures and societies have a strong tradition of organ and tissue donation, which supports the availability of donor corneas and the acceptance of human tissue transplantation.
Based on Region, The Asia Pacific region is witnessing the fastest growth in the Global Corneal Implants Market. This growth is driven by the increasing prevalence of eye disorders such as corneal blindness, rising healthcare investments, and advancements in ophthalmic technologies across countries like China, India, Japan, and South Korea. Additionally, the growing awareness of eye health, along with expanding access to healthcare services and improved surgical facilities, is further fueling demand for corneal implants. The region’s growing aging population and rising healthcare expenditures are also contributing to the rapid expansion of the market in Asia Pacific.
Some of the major companies
operating in the Global Corneal
Implants Market include:
- Florida
Lions Eye Bank
- Alcon
Inc.
- Auro
Laboratories Ltd.
- CorneaGen
Inc.
- AJL
Ophthalmic S.A.
- DIOPTEX
- Massachusetts
Eye and Ear Associates Inc.
- San
Diego Eye Bank
- KeraMed,
Inc.
- Presbia
PLC
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“Certain areas, particularly in North
America, are projected to exert significant demand for Corneal Implants. The
growth in the competitive landscape and the presence of well-established
companies in the market, committed to enhance the overall wellbeing of people each
year, are expected to contribute to a remarkable growth of the Global Corneal
Implants Market in the forecast period," said Mr. Karan Chechi, Research
Director of TechSci Research, a research-based Global management consulting
firm.
"Corneal Implants Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, others), By Type (Human Cornea, Synthetic) by Surgery (Penetrating Keratoplasty, Endothelial Keratoplasty), By Region, and Competition, 2020-2030F", has
evaluated the future growth potential of Global Corneal Implants Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide innovative market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Corneal Implants Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel:
+13322586602
Email:
sales@techsciresearch.com
Website:
www.techsciresearch.com